Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
- PMID: 30788634
- PMCID: PMC6886235
- DOI: 10.1007/s10552-019-01139-5
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
Abstract
Background: Obesity is a strong risk factor for endometrial cancer, but it is unclear whether metabolic syndrome (MetS) contributes to endometrial cancer risk over and above the contribution of obesity.
Methods: We examined the association of MetS and its components with risk of endometrial cancer in a sub-cohort of 24,210 women enrolled in the Women's Health Initiative cohort study. Two variants of the National Cholesterol Education Program Adult Treatment Panel III definition of the MetS were used: one including and one excluding waist circumference (WC). Cox proportional hazards models were used to estimate the association of the study exposures with disease risk.
Results: When WC was included in the definition, MetS showed an approximately two-fold increase in endometrial cancer risk (HR 2.20; 95% CI 1.61-3.02); however, when WC was excluded, MetS was no longer associated with risk. We also observed that women with hyperglycemia, dyslipidemia and hypertension, in combination, had almost a twofold increased risk of endometrial cancer, independent of WC (HR 1.94; 95% CI 1.09, 3.46). Glucose, and, in particular, WC and body mass index were also positively associated with risk.
Conclusions: Our findings suggest that MetS may predict risk of endometrial cancer independent of obesity among women with the remaining four Mets components.
Keywords: Abdominal adiposity; Endometrial cancer; Metabolic syndrome; Obesity; Postmenopausal women.
Conflict of interest statement
References
-
- Grundy SM, Cleeman JI, Daniels ST, Donato KA, Eckel RH, Franklin BA et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752 - PubMed
-
- Galassi A, Reynolds K, He J (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119:812–919 - PubMed
-
- Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diab Care 26:3153–3159 - PubMed
-
- Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjønneland A et al. (2007) Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14:755–767 - PubMed